GMAB

Genmab A/S

Genmab A/S is a leading biotechnology company that specializes in developing innovative antibody therapeutics for cancer treatment. Established in 1999, the company has a strong focus on research and development, with a pipeline of promising drug candidates in various stages of clinical development. Genmab's flagship product, Darzalex, is a first-in-class antibody therapy for multiple myeloma, approved in over 90 countries worldwide. The company's DuoBody technology platform enables the creation of bispecific antibodies that can target multiple disease targets simultaneously, offering a potential breakthrough in cancer treatment. With a global presence and a team of over 600 employees, Genmab is dedicated to improving the lives of cancer patients through the development of innovative and effective therapies.

Instrument specification for Genmab A/S

Name GMAB_CFD.DK
Minimum order value 1
Description Genmab A/S
Maximum order value 150
Transaction Step 1
Type Equities DK
Trading Hours monday-friday 09:01-16:54
Contract size / 1 lot Price * 1 DKK
Deposit required 20%
Value of 1 pip 0.01
Financial leverage 5:1
Minimal step 0.01
Long swap (daily) -0.01808%
Short sale YES
Short swap (daily) 0.00142%
Distance SL and TP 0
3-day swap (date) 5

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top